Across 2024, top immunology news focused on ankylosing spondylitis, psoriatic arthritis, and rheumatoid arthritis, ...
He recalled an exercise where his football coach had players run on the spot. At the sound of a whistle, the players had to ...
He said he was escorted out by two Greenville Police officers after managers of the movie theater said the special chair he ...
Last year, the well-known civil rights activist was escorted out by police from the AMC Fire Tower 12 theater in Greenville ...
Bishop William Barber II filed a lawsuit Thursday morning against AMC Theaters for violating his rights under the ADA when he ...
Bishop William Barber II will announce the federal lawsuit against AMC Theaters tomorrow at a news conference.
Developed by Johnson & Johnson, SIMPONI is an anti-TNF biologic medicine that targets and blocks a protein called TNF-alpha.
Bishop William Barber II was at The Hope Center at Pullen in Raleigh Thursday morning to hold a news conference about a ...
As AbbVie Ireland’s new general manager, Dana Kendall will oversee the company’s commercial business in the country.
India Today on MSN5d
With winter comes joint pain: How to stay fitterThe discomfort is often linked to preexisting arthritic conditions, reduced mobility or increased muscle stiffness, all of ...
Risk adjusted net present value: What is the current valuation of UCB’s (Doxecitine + Doxribtimine)?
(Doxecitine + Doxribtimine) is a small molecule commercialized by UCB, with a leading Phase III program in Inherited Mitochondrial Disorders.
Assertio (NASDAQ:ASRT – Get Free Report)‘s stock had its “buy” rating restated by investment analysts at HC Wainwright in a research report issued on Monday,Benzinga reports. They presently have a $4.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback